Found 16 hits of Enzyme Inhibition Constant Data
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.670nMAssay Description:Inhibition of CCR2 in human THP1 cells assessed as reduction in MCP1-induced chemotaxis measured after 10 mins by calcein-AM dye based fluorescence a...More data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
3D Structure (crystal)TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.90nMAssay Description:Displacement of [125I]MCP1 from CCR2 in human PBMC measured after 30 minsMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 287nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 780nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.57E+3nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 1.64E+3nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataIC50: 3.47E+3nMAssay Description:Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Bristol-Myers Squibb Company
Curated by ChEMBL
Bristol-Myers Squibb Company
Curated by ChEMBL
Affinity DataKd: 24nMAssay Description:Binding affinity to CCR5 in T-cell (unknown origin)More data for this Ligand-Target Pair
